Genomics and Randomized Trials Network (GARNET)
The Genomics and Randomized Trials Network (GARNET) is series of genome-wide association studies of treatment response in randomized clinical trials. The goal of GARNET was to identify genetic variants associated with response to treatments for conditions of clinical or public health significance.
GENEVA - Part of the Genetics Program of GEI, GENEVA (Gene Environment Association Studies) is using rapidly evolving technologies in Genome-Wide Association Studies (GWAS) to find genetic risk factors in common conditions, such as tooth decay, heart disease, cancer and diabetes, and assess their interplay with non-genetic risk factors.
Molecular Libraries and Imaging Program (MLI)
Created in 2005 under the NIH Common Fund to support the high-throughput screening of small molecules that could potentially be used by researchers for drug development or the study of cellular processes related to disease.